Premenstrual Dysphoric Disorder clinical trials
The registry lists 42 studies for Premenstrual Dysphoric Disorder across more than 10 countries. 10 are recruiting or about to start. 35 of them are mainly about Premenstrual Dysphoric Disorder (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Premenstrual Dysphoric Disorder studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of North Carolina, Chapel Hill (4) · Weill Medical College of Cornell University (2) · Cairo University (2) · Bayer (2) · Johns Hopkins University (2) · Tel-Aviv Sourasky Medical Center (2) · Midwestern University (1) · Pherin Pharmaceuticals, Inc. (1)
What is being tested here
Drugs under test in Premenstrual Dysphoric Disorder studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health · University Hospital, Strasbourg, France
- Jan 2027CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life · Samphire Group, Inc.
- Aug 2027To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls. · Lancaster University
- Sep 2027MLS101 Study in PMDD · MycoMedica Life Sciences PBC
Who these studies take
Of the 7 Premenstrual Dysphoric Disorder studies recruiting now, 1 (14%) set no upper age limit and 6 (86%) stop at 75 or younger. 0 (0%) take children under 18. 6 (86%) are for women only and 0 (0%) for men only; 4 (57%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 7 (100%) | 1 (14%) |
| 30 | 7 (100%) | 1 (14%) |
| 40 | 7 (100%) | 1 (14%) |
| 50 | 4 (57%) | 1 (14%) |
| 65 | 2 (29%) | 1 (14%) |
| 75 | 1 (14%) | 1 (14%) |
| 85 | 1 (14%) | 1 (14%) |
Across all 42 studies, recruiting or not: 93% stop at 75 or younger and 93% at 65; 2% take children; 95% are for women only and 0% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 42 of 42. search them.
- MLS101 Study in PMDDNot yet recruitingNCT07818720Phase 1
- Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and PerimenopauseEnrolling by invitationNCT07688720Not applicable1 country
- Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational HealthRecruitingNCT078642851 country
- The SPARK-PMDD StudyNot yet recruitingNCT077714261 country
- To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.RecruitingNCT076867181 country
- CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of LifeRecruitingNCT076790741 country
- Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric DisorderRecruitingNCT06704594Phase 41 country
- Identification and Validation of Epigenetic Biomarkers of PMDDRecruitingNCT067715831 country
- Emotion Regulation-based Internet-delivered Cognitive Behavioural Therapy for Premenstrual Dysphoric DisorderRecruitingNCT06496139Not applicable1 country
- Pilot Study of the 'Thriving With PMDs' ProgramRecruitingNCT06648382Not applicable1 country
- The Effect of Progressive Muscle Relaxation Exercises on Premenstrual Syndrome, Anxiety, and Tendency to Violence in Young WomenCompletedNCT06909955Not applicable1 country
- Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood SymptomsActive, not recruitingNCT06462391Not applicable1 country
- Kinesio Taping vs Tele-Pilates for PMSCompletedNCT07063472Not applicable1 country
- Premenstrual Hormonal and Affective State Evaluation (PHASE) ProjectCompletedNCT03862469Not applicable1 country
- Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar DisorderCompletedNCT05098574Phase 21 country
- The Effects of Mixhers HERTIME Supplements on Menstrual SymptomsCompletedNCT06136104Not applicable1 country
- Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25CompletedNCT06227676Phase 2/31 country
- Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric DisorderStatus unknownNCT05813366Not applicable
- Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian FemalesStatus unknownNCT053270751 country
- Alternative Treatments for Premenstrual Dysphoric DisorderCompletedNCT01799733Not applicable1 country
- A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)CompletedNCT03697265Phase 24 countries
- Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDDTerminatedNCT02362191Not applicable
- Single Session of tACS in a Depressive EpisodeCompletedNCT03449979Not applicable1 country
- Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric DisorderCompletedNCT00611923Phase 4
- EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood DisordersWithdrawnNCT04123483Phase 41 country
- The Role of GABA and Neurosteroids in Premenstrual Dysphoric DisorderCompletedNCT00678574Phase 41 country
- Treatment of Premenstrual Syndrome - Internet-based Self-helpCompletedNCT01961479Not applicable1 country
- Neurofeedback Treatment of Affective Instability in Premenstrual Dysphoric Disorder(PMDD)Status unknownNCT01945372Not applicable1 country
- Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral ContraceptivesTerminatedNCT00089414Phase 21 country
- Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot StudyCompletedNCT02508103Phase 2/31 country
- Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric DisorderCompletedNCT00536198Phase 41 country
- The Influence of the Menstrual Cycle on Lithium and Sertraline Blood LevelsCompletedNCT013857091 country
- Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)CompletedNCT00927095Phase 41 country
- Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric DisorderStatus unknownNCT01217775Phase 31 country
- Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)Status unknownNCT02448836Not applicable
- Regulatory Post Marketing Surveillance Study on YAZCompletedNCT009982571 country
- A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)CompletedNCT01875718Phase 1/21 country
- YAZ Premenstrual Dysphoric Disorder (PMDD) in ChinaCompletedNCT00824187Phase 31 country
- Altered Calcium and Vitamin D in PMDD or Severe PMSCompletedNCT00005119Not applicable1 country
- Luteal Phase Administration of Paroxetine for the Treatment of PMDDCompletedNCT00620581Phase 31 country
- A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual DysphoriaCompletedNCT00516113Phase 41 country
- Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)CompletedNCT00518570Not applicable1 country